Abstract
The present invention relates in general to specific NCR-derived peptides capable of binding to membrane-associated biomolecules of the tumor cells, said biomolecules comprising at least one sulfated polysaccharide. Preferred peptides are about 7 to about 120 amino acids in length and are derived from NKp-44, NKp30 or NKp46.
| Original language | English |
|---|---|
| Patent number | WO2005051973 |
| IPC | C07K 14/ 705 A I |
| Priority date | 25/11/03 |
| State | Published - 9 Jun 2005 |